enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN)


$6.0500
+0.0900 ( -0.82% ) 24.9K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open


$6.0500

Previous close


$5.9600

Volume


24.9K

Market cap


$317.59M

Day range


$6.0550 - $6.5500

52 week range


$4.4200 - $18.4000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Oct 01, 2024
8-k 8K-related 21 Sep 26, 2024
10-q Quarterly Reports 84 Sep 10, 2024
8-k 8K-related 13 Sep 10, 2024
8-k 8K-related 37 Sep 05, 2024
4 Insider transactions 1 Jul 25, 2024
3 Insider transactions 2 Jul 25, 2024
8-k 8K-related 18 Jul 24, 2024
4 Insider transactions 1 Jul 24, 2024
3 Insider transactions 2 Jul 24, 2024

Latest News